Discovery of dopamine D4 receptor antagonists with planar chirality

被引：7

作者：

Sanna, Fabrizio ^{[1
]}

Ortner, Birgit ^{[1
]}

Huebner, Harald ^{[1
]}

Loeber, Stefan ^{[1
]}

Tschammer, Nuska ^{[1
]}

Gmeiner, Peter ^{[1
]}

机构：

[1] Univ Erlangen Nurnberg, Dept Med Chem, Emil Fischer Ctr, D-91052 Erlangen, Germany

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2013年 / 21卷 / 07期

关键词：

GPCR; Dopamine; Subtype selectivity; Ligand efficacy; Paracyclophane; Planar chirality; PENILE ERECTION; PARTIAL AGONISTS; HIGH-AFFINITY; CYCLIC-AMP; CELL-LINE; BINDING; LIGANDS; DERIVATIVES; SUBTYPE; BIOISOSTERES;

D O I：

10.1016/j.bmc.2013.01.065

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Employing the D-4 selective phenylpiperazine 2 as a lead compound, planar chiral analogs with paracyclophane substructure were synthesized and evaluated for their ability to bind and activate dopamine receptors. The study revealed that the introduction of a [2.2]paracyclophane moiety is tolerated by dopamine receptors of the D-2 family. Subtype selectivity for D-4 and ligand efficacy depend on the absolute configuration of the test compounds. Whereas the achiral single-layered lead 2 and the double-layered paracyclophane (R)-3 showed partial agonist properties, the enantiomer (S)-3 behaved as a neutral antagonist. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：1680 / 1684

页数：5

共 50 条

[11] Dopamine D4 receptor antagonists (4): Benzylidenepiperidine and arylpiperidine derivatives.
Nakazato, A
Kumagai, T
Nagamine, M
Kondoh, K
Chaki, S
Yoshikawa, R
Funakoshi, T
Okuyama, S
Yoshida, M
Tomisawa, K
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U239 - U239
[12] A 3D QSAR study on a set of dopamine D4 receptor antagonists
Boström, J
Böhm, M
Gundertofte, K
Klebe, G
[J]. JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES, 2003, 43 (03): : 1020 - 1027
[13] Leukotriene D4 receptor antagonists
Lloyd, AW
[J]. DRUG DISCOVERY TODAY, 1999, 4 (01) : 39 - 40
[14] Novel Dopamine D4 Receptor-Selective Antagonists For Neuropsychiatric Disorders
Keck, Thomas M.
Kelshikar, Shreya
Shah, Nisha
McBride, Connor
Sanchez, Moises Ximello
Panasis, Diandra
Maslonka, Brianna
Muccilli, Abigail
Ladik, Maria
Akca, Ebrar
Ginet, Sophia
[J]. FASEB JOURNAL, 2022, 36
[15] Dopamine D4 receptor ubiquitination
Skieterska, Kamila
Rondou, Pieter
Van Craenenbroeck, Kathleen
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 601 - 605
[16] Dopamine D4 receptor antagonist
Lloyd, AW
[J]. DRUG DISCOVERY TODAY, 1998, 3 (07) : 351 - 351
[17] THE DOPAMINE D4 RECEPTOR AND SCHIZOPHRENIA
KENNEDY, JL
PETRONIS, A
MACCIARDI, F
VANTOL, HHM
SEEMAN, P
[J]. SCHIZOPHRENIA RESEARCH, 1994, 11 (02) : 145 - 145
[18] Isoxazolylpyrrolidinylpiperazine Ligands, a New Class for Dopamine D3 and D4 Receptor Antagonists
Oh, Yoo Na
Kwak, Jumyung
Koh, Hun Yeong
Jung, Sun Ho
[J]. BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2012, 33 (12) : 4227 - 4230
[19] Discovery of selective dopamine D4 receptor antagonists: 1-aryloxy-3-(4-aryloxypiperidinyl)-2-propanols
Wright, JL
Gregory, TF
Heffner, TG
MacKenzie, RG
Pugsley, TA
Meulen, SV
Wise, LD
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (11) : 1377 - 1380
[20] The dopamine D4 receptor in schizophrenia: An update
Kerwin, RW
Collier, D
[J]. PSYCHOLOGICAL MEDICINE, 1996, 26 (02) : 221 - 227

← 1 2 3 4 5 →